Switch to:

Fate Therapeutics PS Ratio

: 216.00 (As of Today)
View and export this data going back to 2013. Start your Free Trial

As of today, Fate Therapeutics's share price is $37.80. Fate Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2020 was $0.18. Hence, Fate Therapeutics's P/S Ratio for today is 216.00.

Warning Sign:

Fate Therapeutics Inc stock PS Ratio (=240.76) is close to 5-year high of 240.76

NAS:FATE' s PS Ratio Range Over the Past 10 Years
Min: 10.45   Med: 132.79   Max: 656.36
Current: 216

10.45
656.36

During the past 9 years, Fate Therapeutics's highest P/S Ratio was 656.36. The lowest was 10.45. And the median was 132.79.

NAS:FATE's PS Ratio is ranked lower than
84% of the 888 Companies
in the Biotechnology industry.

( Industry Median: 17.39 vs. NAS:FATE: 216.00 )

Fate Therapeutics's Revenue per Sharefor the three months ended in Jun. 2020 was $0.07. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2020 was $0.18.

During the past 12 months, the average Revenue per Share Growth Rate of Fate Therapeutics was 35.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 4.10% per year.

During the past 9 years, Fate Therapeutics's highest 3-Year average Revenue per Share Growth Rate was 4.10% per year. The lowest was -100.00% per year. And the median was -5.60% per year.

Back to Basics: P/S Ratio


Fate Therapeutics PS Ratio Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Fate Therapeutics Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
PS Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.74 17.68 62.35 154.58 124.65

Fate Therapeutics Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
PS Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 157.36 106.37 124.65 149.06 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Fate Therapeutics PS Ratio Distribution

* The bar in red indicates where Fate Therapeutics's PS Ratio falls into.



Fate Therapeutics PS Ratio Calculation

The P/S Ratio is another ratio widely used to value stocks. It was first used by Ken Fisher.

Fate Therapeutics's P/S Ratio for today is calculated as

P/S Ratio=Share Price/Revenue per Share (TTM)
=37.80/0.175
=216.00

Fate Therapeutics's Share Price of today is $37.80.
Fate Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2020 was 0.036 (Sep. 2019 ) + 0.037 (Dec. 2019 ) + 0.033 (Mar. 2020 ) + 0.069 (Jun. 2020 ) = $0.18.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

It can also be calculated from the numbers for the whole company:

P/E Ratio=Market Cap/Revenue

The revenue here is for the trailing 12 months.


Fate Therapeutics  (NAS:FATE) PS Ratio Explanation

The P/S ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The P/S ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The P/S ratio is a great valuation tool for evaluating cyclical businesses where the P/E ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the P/S ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the Price/Earnings ratio and Price/Cash Flow or Price/Free Cash Flow, the P/E ratio measures the valuation based on the earning power of the company. This is where it is different from Price/Book ratio, which measures the valuation based on the company's balance sheet.


Be Aware

The P/S ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Fate Therapeutics PS Ratio Related Terms


Fate Therapeutics PS Ratio Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)